MedTech Acquisition in its latest filing said it closed its IPO of 25 million units, including 3 million units upon a partial exercise of the underwriters’ over-allotment option.
With units priced at $10 each, the IPO generated $250 million.
Simultaneously with the closing of the IPO, the SPAC completed a private sale of 4.93 million warrants to MedTech Acquisition Sponsor, generating $7.4 million.
MedTech is focused on the US medical technology and healthcare sectors. Read more.
